Improvement of adult Still's disease with granulocyte and monocyte adsorption apheresis
- 9 July 2004
- journal article
- case report
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 29 (4), 410-412
- https://doi.org/10.1111/j.1365-2230.2004.01502.x
Abstract
Adult Still's disease is characterized by a high spiking fever, transient skin rash, and polyarthralgia. Joint pain is one of the major complaints and is often intractable. We assessed the efficacy of granulocyte and monocyte adsorption apheresis (GCAP) therapy for treating arthralgia in adult Still's disease. A 33‐year‐old woman with adult Still's disease who suffered from recalcitrant arthralgia resistant to systemic corticosteroids was treated with GCAP therapy. She underwent five GCAP treatments at 5‐day intervals. Her joint pain responded dramatically to the GCAP therapy, suggesting that GCAP may be useful for treating adult Still's disease. We present a detailed description of the patient and this novel therapy.Keywords
This publication has 6 references indexed in Scilit:
- Treatment of psoriatic arthritis with granulocyte and monocyte adsorption apheresisJournal of the American Academy of Dermatology, 2004
- Improvement of SLE Skin Rash with Granulocyte and Monocyte Adsorption ApheresisDermatology, 2004
- Treatment of pustular psoriasis with granulocyte and monocyte adsorption apheresisJournal of the American Academy of Dermatology, 2003
- Granulocyte and monocyte adsorption apheresis for pyoderma gangrenosum?Journal of the American Academy of Dermatology, 2002
- A subpopulation of Mac-1 (CD11b/CD18) molecules mediates neutrophil adhesion to ICAM-1 and fibrinogen.The Journal of cell biology, 1993
- Still's disease in the adult.Annals Of The Rheumatic Diseases, 1971